AstraZeneca PLC (AZN) vs Johnson & Johnson (JNJ)
A side-by-side comparison of AstraZeneca PLC and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
AZN
AstraZeneca PLC
$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT
JNJ
Johnson & Johnson
$266.73HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — AZN vs JNJ
growth of $100 · dividends reinvested · last 30yAZN +2029.9%JNJ +2166.3%JNJ compounded faster
AZN JNJ
AZN vs JNJ: by the numbers
- •JNJ is the larger company ($642.79B vs $133.67B market cap).
- •AZN trades at the lower trailing earnings multiple (12.77 vs 30.82 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 17.19% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 2.93% CAGR).
- •JNJ pays the higher dividend yield (1.97% vs 1.89%).
Metrics side by side
Valuation
| Metric | AZN | JNJ |
|---|---|---|
| P/E ratio | 12.77 | 30.82 |
| Forward P/E | 16.58 | 22.76 |
| P/S ratio | 2.19 | 6.63 |
| P/B ratio | 2.80 | 7.64 |
| PEG ratio | 0.29 | 0.21 |
| EV / EBITDA | 7.89 | 19.98 |
| FCF yield | 6.09% | 3.48% |
Profitability
| Metric | AZN | JNJ |
|---|---|---|
| Gross margin | 81.68% | 70.45% |
| Operating margin | 23.69% | 26.81% |
| Net margin | 17.19% | 21.48% |
| ROE | 21.95% | 24.76% |
| ROIC | 13.03% | 13.71% |
Dividends
| Metric | AZN | JNJ |
|---|---|---|
| Dividend yield | 1.89% | 1.97% |
| Payout ratio | 24.24% | 47.51% |
Growth (annualized)
| Metric | AZN | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 2.93% |
| EPS CAGR (5Y) | 22.02% | 11.51% |
| FCF CAGR (5Y) | 15.68% | -0.49% |
| Total return CAGR (5Y) | 10.56% | 12.13% |
Frequently asked
- Which has the lower trailing P/E, AZN or JNJ?
- AZN has the lower trailing P/E: AZN trades at 12.77 and JNJ at 30.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AZN or JNJ?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus JNJ at 2.93%.
- Does AZN or JNJ pay a bigger dividend?
- AZN yields 1.89% and JNJ yields 1.97% based on trailing dividends and the latest price.
- Is AZN or JNJ more profitable?
- JNJ runs the higher net margin — AZN at 17.19% versus JNJ at 21.48%.
- How have AZN and JNJ total returns compared?
- Over the past 10 years, AZN delivered 13.96% and JNJ delivered 10.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioJohnson & Johnson P/E ratioAstraZeneca dividend yieldJohnson & Johnson dividend yieldAstraZeneca ROEJohnson & Johnson ROEAstraZeneca operating marginJohnson & Johnson operating marginAstraZeneca revenue growthJohnson & Johnson revenue growthAstraZeneca free cash flowJohnson & Johnson free cash flow
AstraZeneca & Johnson & Johnson appear in these rankings
25+ Year Dividend GrowersFastest Revenue Growth StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.